High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease-Reference-Cited by-同舟云学术

High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease

Published:2018-09-28 Issue:11 Volume:58 Page:2564-2571
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Nolan Brian E.¹,Wang Yunfei²,Pary Philippe P.³,Luban Naomi L.C.¹²³⁴⁵,Wong Edward C.C.¹²³⁴⁵,Ronis Tova¹²⁶

Affiliation:

1. Department of Pediatrics; Washington DC

2. Center for Translational Science; Washington DC

3. Division of Laboratory Medicine; Center for Cancer and Blood Disorders, George Washington School of Medicine and Health Sciences, Children's National Health System; Washington DC

4. Division of Hematology; Center for Cancer and Blood Disorders, George Washington School of Medicine and Health Sciences, Children's National Health System; Washington DC

5. Department of Pathology; Center for Cancer and Blood Disorders, George Washington School of Medicine and Health Sciences, Children's National Health System; Washington DC

6. Division of Rheumatology; Center for Cancer and Blood Disorders, George Washington School of Medicine and Health Sciences, Children's National Health System; Washington DC

Funder

National Center for Advancing Translational Sciences

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.14879/fullpdf

Reference28 articles.

1. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association;McCrindle;Circulation,2017

2. Intravenous gamma-globulin for Kawasaki disease;Furusho;Acta Paediatr Jpn Overseas Ed,1991

3. Corticosteroids for the treatment of Kawasaki disease in children;Wardle;Cochrane Database Syst Rev,2017